10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
PFIZER INC | ||
Ticker: PFE Fiscal Year: 2017 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2017 10-K (Filed: Feb 22, 2018) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2017 | Dec 31, 2016 | |
| Assets | ||
| Cash and cash equivalents | $ 1,342 | 2,595 |
| Short-term investments | 18,650 | 15,255 |
| Trade accounts receivable, less allowance for doubtful accounts: 2017$584; 2016$609 | 8,221 | 8,225 |
| Inventories | 7,578 | 6,783 [1] |
| Current tax assets | 3,050 | 3,041 |
| Other current assets | 2,289 | 2,249 |
| Assets held for sale | 12 | 801 |
| Total current assets | 41,141 | 38,949 |
| Long-term investments | 7,015 | 7,116 |
| Property, plant and equipment, less accumulated depreciation | 13,865 | 13,318 [2] |
| Identifiable intangible assets, less accumulated amortization | 48,741 [3] | 52,648 |
| Goodwill | 55,952 | 54,449 |
| Noncurrent deferred tax assets and other noncurrent tax assets | 1,855 | 1,812 |
| Other noncurrent assets | 3,227 | 3,323 |
| Total assets | 171,797 | 171,615 |
| Liabilities and Equity | ||
| Short-term borrowings, including current portion of long-term debt: 2017$3,546; 2016$4,225 | 9,953 | 10,688 |
| Trade accounts payable | 4,656 | 4,536 |
| Dividends payable | 2,029 | 1,944 |
| Income taxes payable | 477 | 437 |
| Accrued compensation and related items | 2,196 | 2,487 |
| Other current liabilities | 11,115 | 11,023 |
| Total current liabilities | 30,427 | 31,115 |
| Long-term debt | 33,538 | 31,398 |
| Pension benefit obligations, net | 5,926 | 6,406 |
| Postretirement benefit obligations, net | 1,504 | 1,766 |
| Noncurrent deferred tax liabilities | 3,900 | 30,753 |
| Other taxes payable | 18,697 | 4,000 |
| Other noncurrent liabilities | 6,149 | 6,337 |
| Total liabilities | 100,141 | 111,776 |
| Commitments and Contingencies | ||
| Preferred stock, no par value, at stated value; 27 shares authorized; issued: 2017-524; 2016-597 | 21 | 24 |
| Common stock, $0.05 par value; 12,000 shares authorized; issued: 2017-9,275; 2016-9,230 | 464 | 461 |
| Additional paid-in capital | 84,278 | 82,685 |
| Treasury stock, shares at cost: 20173,296; 2016-3,160 | (89,425) | (84,364) |
| Retained earnings | 85,291 | 71,774 |
| Accumulated other comprehensive loss | (9,321) | (11,036) |
| Total Pfizer Inc. shareholders equity | 71,308 | 59,544 |
| Equity attributable to noncontrolling interests | 348 | 296 |
| Total equity | 71,656 | 59,840 |
| Total liabilities and equity | 171,797 | 171,615 |
| [1] The change from December 31, 2016 reflects the build of inventory primarily for and in advance of new or potential product launches and increases to meet targeted levels for certain products in the normal course of business, as well as an increase due to foreign exchange. | ||
| [2] The increase in total property, plant and equipment is primarily due to capital additions and the impact of foreign exchange, partially offset by depreciation, reductions due to restructuring efforts and disposals. | ||
| [3] The decrease in Identifiable intangible assets, less accumulated amortization, is primarily due to (i) amortization, (ii) measurement period adjustments related to Medivation (see Note 2A), as well as (iii) impairments of Developed technology rights (see Note 4), partially offset by (iv) assets acquired as part of the acquisition of AstraZenecas small molecule anti-infectives business (see Note 2A), (v) the assets recorded in connection with the EU and U.S. approvals of Besponsa and in connection with the | ||
| External Links | |
| PFIZER INC (PFE) Fiscal Year 2017 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |